Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-017850

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kasahara Noriyuki · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +45,000 45,000 D
Loading xslF345X03/doc1.xml…